AAMU
PRAH

Amundi Asset Management US’s PRA Health Sciences, Inc. PRAH Stock Holding History

Amundi Asset Management US’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$770K Sell
5,019
-2,218
-31% -$301K ﹤0.01% 1283
2020
Q4 		$908K Buy
7,237
+455
+7% +$50.9K ﹤0.01% 1229
2020
Q3 		$688K Hold
6,782
– – ﹤0.01% 1222
2020
Q2 		$660K Hold
6,782
– – ﹤0.01% 1217
2020
Q1 		$563K Sell
6,782
-7,289
-52% -$711K ﹤0.01% 1183
2019
Q4 		$1.56M Hold
14,071
– – ﹤0.01% 1173
2019
Q3 		$1.4M Buy
14,071
+1,500
+12% +$149K ﹤0.01% 1181
2019
Q2 		$1.25M Buy
12,571
+5,574
+80% +$532K ﹤0.01% 1219
2019
Q1 		$772K Buy
6,997
+5,400
+338% +$564K ﹤0.01% 1250
2018
Q4 		$147 Sell
1,597
-14,724
-90% -$1.49M ﹤0.01% 1439
2018
Q3 		$1.8M Sell
16,321
-9,612
-37% -$1M ﹤0.01% 1155
2018
Q2 		$2.42M Buy
+25,933
New +$2.23M ﹤0.01% 1082

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Amundi Asset Management US's PRAH Position: Q1 2021 in Review

Amundi Asset Management US reduced its PRA Health Sciences, Inc. (PRAH) stake by 31% in Q1 2021, selling an estimated $301K and leaving 5,019 shares worth $770K. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

Amundi Asset Management US first reported a position in PRAH in Q2 2018 and has held it in 12 quarters since. The position peaked at $2.42M in Q2 2018. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Amundi Asset Management US held 5,019 shares of PRA Health Sciences, Inc. worth $770K as of Q1 2021.
  • Amundi Asset Management US sold 2,218 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $301K.
  • PRA Health Sciences, Inc. made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1283 holding.
  • Amundi Asset Management US first reported a position in PRA Health Sciences, Inc. in Q2 2018 and has held it in 12 quarters since.
  • Amundi Asset Management US's PRA Health Sciences, Inc. position peaked at $2.42M in Q2 2018.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.